COLOMBO NICOLETTA

Ruolo:
Professoressa associata
Settore scientifico disciplinare:
Ginecologia e ostetricia (MEDS-21/A)
Gruppo scientifico disciplinare:
GINECOLOGIA E OSTETRICIA (06/MEDS-21)

Pubblicazioni

  • Lorusso, D., Oaknin, A., Borges, G., Damian, F., Ottevanger, N., Van Gorp, T., et al. (2025). Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial. GYNECOLOGIC ONCOLOGY, 196(May 2025), 28-35 [10.1016/j.ygyno.2025.03.019]. Dettaglio

  • De Vitis, L., Schivardi, G., Gaeta, A., Caruso, G., Rosanu, M., Ribero, L., et al. (2025). External validation of the Annual Recurrence Risk Model (ARRM) for tailored surveillance strategy in patients with cervical cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(6 (June 2025)) [10.1016/j.ijgc.2025.101756]. Dettaglio

  • Lorusso, D., Colombo, N., Dubot, C., Cáceres, M., Hasegawa, K., Shapira-Frommer, R., et al. (2025). Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study. ANNALS OF ONCOLOGY, 36(1), 65-75 [10.1016/j.annonc.2024.10.002]. Dettaglio

  • Quesada, S., Penault-Llorca, F., Matias-Guiu, X., Banerjee, S., Barberis, M., Coleman, R., et al. (2025). Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics. EUROPEAN JOURNAL OF CANCER, 215(17 January 2025) [10.1016/j.ejca.2024.115169]. Dettaglio

  • Bogani, G., Moore, K., Ray-Coquard, I., Lorusso, D., Matulonis, U., Ledermann, J., et al. (2025). Incorporating immune checkpoint inhibitors in epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY, 193(February 2025), 30-40 [10.1016/j.ygyno.2024.12.011]. Dettaglio